From the book reviews: "Editors S. Campbell and B. Rini, with the support of 40 experts, aimed to come out with an update on recent innovations, focusing on clinical implications. ... A very well-illustrated chapter dealt with various pathological aspects of RCC, including molecular genetics, while another chapter focused on family diseases. ... This textbook offers practical information which is of special interest to all urologists and oncologists involved in RCC management." (European Urology Today, Vol. 25 (3), June-July, 2013) "This is a concise but comprehensive review of renal cell carcinoma from etiology and risk factors to medical and surgical management. ... This is an excellent resource for any practitioner with an interest in renal cell carcinoma. ... this book would appeal to general oncologists, urologists, general surgeons, radiologists, pathologists, nephrologists, internists, family practitioners, fellows, residents, and students. ... It is thorough, clearly written, and logically presented." (Jean Hoffman-Censits, Doody's Book Reviews, February, 2013)

• Section I: Localized Disease.- 1.Etiology of RCC: Incidence, Demographics, and Environmental Factors.- 2.Pathology of Renal Cell Carcinoma.- 3.Familial Renal Cell Carinoma.- 4.Imaging of Renal Cell Carcinoma.- 5.Prognostic Factors for Localized Renal Cell Carcinoma.- Section II: Management of Localized RCC.- 6.Assessment of Oncologic Risk for Clinical Stage T1 Renal Tumors and the Emerging Role of Renal Mass Biopsy.- 7.Radical Nephrectomy for Localized Renal Tumors: Oncological and Renal Functional Considerations.- 8.Nephron-Sparing Surgery for Renal Cancer.- 9.Thermal Ablation.- 10.Active Surveillance of the Small Renal Mass.- Section III: Locally Advanced Disease.- 11.Locally Advanced Renal Cell Carcinoma.- 12.Neoadjuvant Targeted Therapy and Consolidative Surgery.- Section IV: Advanced Disease.- 13.Biology of RCC (VEGF, mTOR, immune aspects).- 14.Prognostic Factors in Advanced Renal Cell Carcinoma.- 5.Integration of Surgery in Metastatic Renal Cancer.- 16.Immunotherapy for Renal Cell Carcinoma.- 17.Targeted Therapy: Vascular Endothelial Growth Factor (VEGF).- 18.mTOR in Renal cell carcinoma.- 19.Palliative and Supportive Care for Renal Cancer.

From the book reviews: "Editors S. Campbell and B. Rini, with the support of 40 experts, aimed to come out with an update on recent innovations, focusing on clinical implications. ... A very well-illustrated chapter dealt with various pathological aspects of RCC, including molecular genetics, while another chapter focused on family diseases. ... This textbook offers practical information which is of special interest to all urologists and oncologists involved in RCC management." (European Urology Today, Vol. 25 (3), June-July, 2013) "This is a concise but comprehensive review of renal cell carcinoma from etiology and risk factors to medical and surgical management. ... This is an excellent resource for any practitioner with an interest in renal cell carcinoma. ... this book would appeal to general oncologists, urologists, general surgeons, radiologists, pathologists, nephrologists, internists, family practitioners, fellows, residents, and students. ... It is thorough, clearly written, and logically presented." (Jean Hoffman-Censits, Doody's Book Reviews, February, 2013)

• Section I: Localized Disease.- 1.Etiology of RCC: Incidence, Demographics, and Environmental Factors.- 2.Pathology of Renal Cell Carcinoma.- 3.Familial Renal Cell Carinoma.- 4.Imaging of Renal Cell Carcinoma.- 5.Prognostic Factors for Localized Renal Cell Carcinoma.- Section II: Management of Localized RCC.- 6.Assessment of Oncologic Risk for Clinical Stage T1 Renal Tumors and the Emerging Role of Renal Mass Biopsy.- 7.Radical Nephrectomy for Localized Renal Tumors: Oncological and Renal Functional Considerations.- 8.Nephron-Sparing Surgery for Renal Cancer.- 9.Thermal Ablation.- 10.Active Surveillance of the Small Renal Mass.- Section III: Locally Advanced Disease.- 11.Locally Advanced Renal Cell Carcinoma.- 12.Neoadjuvant Targeted Therapy and Consolidative Surgery.- Section IV: Advanced Disease.- 13.Biology of RCC (VEGF, mTOR, immune aspects).- 14.Prognostic Factors in Advanced Renal Cell Carcinoma.- 5.Integration of Surgery in Metastatic Renal Cancer.- 16.Immunotherapy for Renal Cell Carcinoma.- 17.Targeted Therapy: Vascular Endothelial Growth Factor (VEGF).- 18.mTOR in Renal cell carcinoma.- 19.Palliative and Supportive Care for Renal Cancer.

From the book reviews: "Editors S. Campbell and B. Rini, with the support of 40 experts, aimed to come out with an update on recent innovations, focusing on clinical implications. ... A very well-illustrated chapter dealt with various pathological aspects of RCC, including molecular genetics, while another chapter focused on family diseases. ... This textbook offers practical information which is of special interest to all urologists and oncologists involved in RCC management." (European Urology Today, Vol. 25 (3), June-July, 2013) "This is a concise but comprehensive review of renal cell carcinoma from etiology and risk factors to medical and surgical management. ... This is an excellent resource for any practitioner with an interest in renal cell carcinoma. ... this book would appeal to general oncologists, urologists, general surgeons, radiologists, pathologists, nephrologists, internists, family practitioners, fellows, residents, and students. ... It is thorough, clearly written, and logically presented." (Jean Hoffman-Censits, Doody's Book Reviews, February, 2013)

• Section I: Localized Disease.- 1.Etiology of RCC: Incidence, Demographics, and Environmental Factors.- 2.Pathology of Renal Cell Carcinoma.- 3.Familial Renal Cell Carinoma.- 4.Imaging of Renal Cell Carcinoma.- 5.Prognostic Factors for Localized Renal Cell Carcinoma.- Section II: Management of Localized RCC.- 6.Assessment of Oncologic Risk for Clinical Stage T1 Renal Tumors and the Emerging Role of Renal Mass Biopsy.- 7.Radical Nephrectomy for Localized Renal Tumors: Oncological and Renal Functional Considerations.- 8.Nephron-Sparing Surgery for Renal Cancer.- 9.Thermal Ablation.- 10.Active Surveillance of the Small Renal Mass.- Section III: Locally Advanced Disease.- 11.Locally Advanced Renal Cell Carcinoma.- 12.Neoadjuvant Targeted Therapy and Consolidative Surgery.- Section IV: Advanced Disease.- 13.Biology of RCC (VEGF, mTOR, immune aspects).- 14.Prognostic Factors in Advanced Renal Cell Carcinoma.- 5.Integration of Surgery in Metastatic Renal Cancer.- 16.Immunotherapy for Renal Cell Carcinoma.- 17.Targeted Therapy: Vascular Endothelial Growth Factor (VEGF).- 18.mTOR in Renal cell carcinoma.- 19.Palliative and Supportive Care for Renal Cancer.